Neutron capture therapy of cancer
Neutron Capture Therapy of Cancer is a non-invasive radiotherapy treatment used to manage malignant tumors. This therapy utilizes the nuclear capture and fission reactions that occur when a non-radioactive isotope, boron-10, is irradiated with low energy thermal neutrons to produce high-energy alpha particles and lithium-7 nuclei.
History[edit]
The concept of Neutron Capture Therapy (NCT) was first proposed in 1936 by Locher. The development of nuclear reactors in the 1950s provided a source of neutrons, and the first clinical trials were conducted in the 1950s and 1960s. However, due to the lack of suitable boron delivery agents and the difficulty in achieving a therapeutic ratio, these early trials were not successful.
Mechanism[edit]
In Neutron Capture Therapy, a compound containing boron-10 is injected into the patient's bloodstream. The compound is designed to accumulate preferentially in tumor cells. The patient is then irradiated with thermal neutrons. The boron-10 in the tumor absorbs the neutrons and undergoes a nuclear reaction, producing high-energy alpha particles and lithium-7 nuclei. These particles have a very short range in tissue, so they deliver a high dose of radiation to the tumor cells, while sparing the surrounding healthy tissue.
Clinical Applications[edit]
Neutron Capture Therapy has been used to treat several types of cancer, including glioblastoma, melanoma, and head and neck cancer. The therapy is particularly effective for tumors that are resistant to conventional radiation therapy or are located in areas that are difficult to treat with surgery.
Challenges and Future Directions[edit]
Despite its potential, Neutron Capture Therapy is not widely used, due to the need for a nuclear reactor to produce the thermal neutrons. However, research is ongoing to develop alternative neutron sources, such as accelerator-based systems. In addition, new boron delivery agents are being developed to improve the selectivity and efficacy of the therapy.
Neutron capture therapy of cancer[edit]
-
Illustration of Boron Neutron Capture Therapy (BNCT)
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian